Novel automated screening of age-related macular degeneration

被引:0
作者
Yasuyuki Yamauchi
Hiroyuki Kemma
Hiroshi Goto
Atsushi Nakamura
Takashi Nagaoka
Takayuki Sota
机构
[1] Tokyo Medical University Hospital,Department of Ophthalmology
[2] Waseda University,Department of Electrical Engineering and Bioscience
[3] Toda Chuo General Hospital,Department of Ophthalmology
[4] Waseda University,Institute for Science and Engineering
来源
Japanese Journal of Ophthalmology | 2012年 / 56卷
关键词
Age-related macular degeneration; Near-infrared hyperspectral imaging; Automated method for screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:577 / 583
页数:6
相关论文
共 109 条
  • [1] Oshima Y(2001)Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study Br J Ophthalmol 85 1153-1157
  • [2] Ishibashi T(2002)Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study Ophthalmology 109 1767-1779
  • [3] Murata T(2006)Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies Ophthalmology 113 29-35
  • [4] Tahara Y(2007)Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study Ophthalmology 114 92-98
  • [5] Kiyohara Y(2010)Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients Jpn J Ophthalmol 54 124-128
  • [6] Kubota T(2003)1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049-1061
  • [7] Klein R(2006)Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP report no. 4 Arch Ophthalmol 124 660-664
  • [8] Klein BE(2006)Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 1432-1444
  • [9] Tomany SC(2006)Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study Arch Ophthalmol 124 1532-1542
  • [10] Meuer SM(2006)Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419-1431